Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients

Dexmedetomidine is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the activity of sympathetic nerve, alleviate pain,and improve cardiovascular stability in the operation period. Dexmedetomidine have influence on perioperative stress response and immune function,but it is not clear.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

92

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shanxi
      • Xi'an, Shanxi, China
        • Recruiting
        • SecondXianJiaotongU
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged 60 to 80 years old;
  • Type 2 diabetes;
  • Not use insulin treatment;
  • Onging general anesthesia surgery;
  • Surgery time 1-3 hours

Exclusion Criteria:

  • ASA classification > class II;
  • Hypertension;
  • Serious central nervous system diseases (acute stroke, uncontrolled seizures, -Severe dementia);
  • Unstable angina and acute myocardial infarction;
  • Allergy to investigational drug;
  • Hepatic and renal dysfunction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: N1 group: Isoflurane & saline
for normal patients: inhale Isoflurane + the same volume of saline during operation
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
the same volume of saline + Isoflurane during operation
EXPERIMENTAL: N2 group: Isoflurane & Dexmedetomidine
for normal patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.
ACTIVE_COMPARATOR: D1 group: Isoflurane & saline
for diabetes patients: inhale Isoflurane + the same volume of saline during operation
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
the same volume of saline + Isoflurane during operation
EXPERIMENTAL: D2 group: Isoflurane & Dexmedetomidi
for diabetes patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation
general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg
inhale Isoflurane 1.5MAC
anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
blood glucose
Time Frame: from the day before surgery to 24 hours after surgery
measure blood glucose at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); examine the concentration of blood glucose in serum.
from the day before surgery to 24 hours after surgery
level of blood insulin
Time Frame: from the day before surgery to 24 hours after surgery
measure the level of blood insulin at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); use ELISA to examine the concentration of blood insulin in serum.
from the day before surgery to 24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
vital signs
Time Frame: duration of perioperative period
measure the blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) in the perioperative period
duration of perioperative period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (ANTICIPATED)

October 1, 2014

Study Completion (ANTICIPATED)

October 1, 2014

Study Registration Dates

First Submitted

May 28, 2014

First Submitted That Met QC Criteria

May 30, 2014

First Posted (ESTIMATE)

June 3, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

June 3, 2014

Last Update Submitted That Met QC Criteria

May 30, 2014

Last Verified

May 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perioperative Blood Glucose and Insulin

Clinical Trials on general anesthesia induction

3
Subscribe